| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.138 | 11.483 | - | 8.682 | 8.228 | 4.818 | 10.761 | 13.622 | 10.385 | 12.633 |
| Total Income - EUR | 9.138 | 11.483 | - | 8.682 | 8.228 | 4.818 | 16.722 | 13.622 | 14.736 | 12.734 |
| Total Expenses - EUR | 8.425 | 9.715 | - | 13.194 | 13.409 | 10.949 | 11.046 | 11.546 | 10.544 | 12.588 |
| Gross Profit/Loss - EUR | 713 | 1.767 | - | -4.511 | -5.182 | -6.130 | 5.677 | 2.076 | 4.192 | 145 |
| Net Profit/Loss - EUR | 438 | 1.537 | - | -4.598 | -5.264 | -6.178 | 5.509 | 1.940 | 4.045 | 18 |
| Employees | 1 | 1 | - | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Biovega Mark Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.126 | 2.724 | - | 843 | 1.213 | 763 | 1.016 | 2.043 | 2.299 | 2.300 |
| Inventories | 1.065 | 1.218 | - | 641 | 874 | 755 | 985 | 1.202 | 1.244 | 1.675 |
| Receivables | 0 | 0 | - | 0 | 0 | 0 | 0 | 683 | 1.012 | 0 |
| Cash | 60 | 1.506 | - | 202 | 339 | 9 | 31 | 157 | 43 | 625 |
| Shareholders Funds | 376 | 1.598 | - | -4.106 | -9.291 | -15.293 | -9.445 | -7.534 | -3.466 | -3.429 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 749 | 1.126 | - | 4.950 | 10.504 | 16.057 | 10.460 | 9.577 | 5.766 | 5.729 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9313 - 9313" | |||||||||
| CAEN Financial Year |
9313
|
|||||||||
Comments - Biovega Mark Srl